BCG and Super Human Network Publish the First Industry Benchmark for the Longevity Sector: Over $21 Billion Invested Across Roughly 1,300 Companies, but the Gap Between Total and Healthy Life Expectancy Has Grown from 8.5 to 9.6 Years

BCG and Super Human Network Publish the First Industry Benchmark for the Longevity Sector: Over $21 Billion Invested Across Roughly 1,300 Companies, but the Gap Between Total and Healthy Life Expectancy Has Grown from 8.5 to 9.6 Years

On September 16, 2026, in Stockholm, the consulting firm Boston Consulting Group (BCG) and the media and distribution company Super Human Network published The Longevity Review 2026, the first annual survey of the longevity industry. The report brings together data on venture funding of longevity companies, a BCG survey of 9,350 people across 19 countries, and interviews with 14 figures in the field. The authors state the publication's goal explicitly: to give the field an evidence-based baseline instead of hype and opinion.

BCG, a consulting firm with more than sixty years of work with major global corporations, has produced its first annual benchmark of the longevity market. The effort was led on BCG's side by Johan Eberg, head of BCG's Tech Capital practice. The partner was Super Human Network, a "trusted distribution platform" for the longevity market; its founder, Ash Pournouri, spent years as manager of the Swedish DJ Avicii. Pournouri explains the motivation in the launch press release:

I've spent my career building movements, and longevity is the biggest one I've seen. Culture is moving faster than evidence. People are drowning in advice and starving for verified facts.

That section of the press release carries the heading "A fast-growing field facing a trust challenge." From 2016 to 2025, annual deal volume in longevity grew nearly sevenfold, and cumulative investment reached over $21 billion across roughly 1,300 companies, though 10% of those companies account for 80% of that total. The same review documents the gap between life expectancy and its healthy portion: global life expectancy rose from 67 to 73 years between 2000 and 2019, while years spent in poor health grew from 8.5 to 9.6, meaning the healthy share of life is growing more slowly than life itself. BCG had already published this finding in September 2025 as the "longevity paradox"; the 2026 report reissues it within a broader benchmark. Even among people over 56 with diagnosed conditions, only 40% take steps toward healthy aging; among younger adults without diagnoses, the figure is 27%.

Eberg frames the same point in market language: "Awareness continues to outpace action. The Longevity Review helps leaders separate long-term opportunity from short-term noise." The list of 14 voices from the field itself mixes quite different levels of scientific standing: alongside researchers of established reputation, such as Eric Verdin, president of the Buck Institute for Research on Aging (a gerontology institute in the United States), Aubrey de Grey, originator of the "longevity escape velocity" concept, and David Sinclair, known for his work on cellular reprogramming, stand wellness-market figures like Bulletproof founder Dave Asprey. Even the "established" half of the roster is uneven: Sinclair already has a $720 million failure with Sirtris and a forced departure from the presidency of the Academy for Health and Lifespan Research following unsubstantiated claims. A reader on the Rapamycin News forum who downloaded all 85 pages wrote: "Their expert list is really more about how well-known these people are than about how good their science is." The same review noted that the report itself labels its capital estimates "indicative" and the proposed upper bound of human lifespan at 120 to 150 years "actively contested," but these qualifications are absent from the executive summary, the section most readers actually finish.

BCG and Super Human Network have produced exactly what they themselves called a "trust challenge." The report documents the industry's central failure: despite growing capital, the number of years lived in poor health continues to rise. Yet the report repeats the same mistake it describes, mixing rigorous scientists with wellness entrepreneurs and leaving methodological caveats outside the summary.